MSB 0.76% $1.31 mesoblast limited

Ann: Confirmatory Phase 3 Back Pain Trial Actively Enrols, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,725 Posts.
    lightbulb Created with Sketch. 5751
    do you think they can thread the needle for an FDA approval and THEN do a cap raise?



    That was the plan last time according to many on here and we all know how that turned out after claiming what a "position of strength we would be in" after an FDA approval


    .... and as I posted, it doesn't necessarily have to be a CLBP partnership - CHF looks the most likely now IMO given the FDA are supportive of an Accelerated Approval pathway for same and the Pre BLA Filing Meeting is scheduled for later this year. Any CHF partner would want to be a part of those negotiations IMO



    upload_2024-7-22_12-51-28.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
-0.010(0.76%)
Mkt cap ! $1.495B
Open High Low Value Volume
$1.31 $1.33 $1.28 $1.819M 1.396M

Buyers (Bids)

No. Vol. Price($)
2 29972 $1.31
 

Sellers (Offers)

Price($) Vol. No.
$1.31 2008 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.